Journal: BMC Microbiology

Article Title: In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program

doi: 10.1186/s12866-022-02644-5

Figure Lengend Snippet: In vitro susceptibilities of Gram-negative isolates obtained from the ATLAS program, 2018

Article Snippet: Quality control strains were used throughout the whole testing process for each batch of MIC tests, including Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 700603, Pseudomonas aeruginosa ATCC 27853, Staphylococcus aureus ATCC 29213, and Streptococcus pneumoniae ATCC 49619.

Techniques: In Vitro

Journal: BMC Microbiology

Article Title: In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program

doi: 10.1186/s12866-022-02644-5

Figure Lengend Snippet: Fold MIC reduction of Gram-negative isolates by addition of avibactam to ceftazidime. eco: Escherichia coli ; kpn: Klebsiella pneumoniae ; ecl: Enterobacter cloacae ; cfr: Citrobacter freundii ; pmi: Proteus mirabilis ; mmo: Morganella morganii ; sma: Serratia marcescens ; aba: Acinetobacter baumannii ; pae: Pseudomonas aeruginosa . Note: a. The MIC 90 fold reduction for K. pneumoniae is actually ≥ 128, for E. cloacae is actually ≥ 256, for P. mirabilis is actually ≥ 128, for A. baumannii is actually ≥ 4. b. The MIC 90 values of ceftazidime and ceftazidime-avibactam for C. freundii are > 128 mg/L and > 64 mg/L. Since they are both off-scale high, this MIC 90 comparison wasn’t shown in Fig. 1

Article Snippet: Quality control strains were used throughout the whole testing process for each batch of MIC tests, including Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 700603, Pseudomonas aeruginosa ATCC 27853, Staphylococcus aureus ATCC 29213, and Streptococcus pneumoniae ATCC 49619.

Techniques: Comparison

Journal: BMC Microbiology

Article Title: In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program

doi: 10.1186/s12866-022-02644-5

Figure Lengend Snippet: In vitro susceptibilities of Gram-positive isolates obtained from the ATLAS program, 2018

Article Snippet: Quality control strains were used throughout the whole testing process for each batch of MIC tests, including Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 700603, Pseudomonas aeruginosa ATCC 27853, Staphylococcus aureus ATCC 29213, and Streptococcus pneumoniae ATCC 49619.

Techniques: In Vitro